Literature DB >> 19776206

Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond.

Emre Bora1, Murat Yücel, Christos Pantelis.   

Abstract

It has recently been suggested that the diagnostic criteria of schizophrenia should include specific reference to cognitive impairments characterizing the disorder. Arguments in support of this assertion contend that such inclusion would not only serve to increase the awareness of cognitive deficits in affected patients, among both clinicians and researchers alike, but also increase the "point of rarity" between schizophrenia and mood disorders. The aim of the current article is to examine this latter assertion in light of the recent opinion piece provided by Keefe and Fenton (Keefe RSE, Fenton WS. How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull. 2007;33:912-920). Through literature review, we explore the issue of whether cognitive deficits do in fact differentiate the major psychoses. The overall results of this inquiry suggest that inclusion of cognitive impairment criteria in Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-V) would not provide a major advancement in discriminating schizophrenia from bipolar disorder and affective psychoses. Therefore, while cognitive impairment should be included in DSM-V, it should not dictate diagnostic specificity--at least not until more comprehensive evidence-based reviews of the current diagnostic system have been undertaken. Based on this evidence, we consider several alternatives for the DSM-V definition of cognitive impairment in schizophrenia, including (1) the inclusion of cognitive impairment as a specifier and (2) the definition of cognitive impairment as a dimension within a hybrid categorical-dimensional system. Given the state of current evidence, these possibilities appear to represent the most parsimonious approaches to the inclusion of cognitive deficits in the diagnostic criteria of schizophrenia and, potentially, of mood disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19776206      PMCID: PMC2800141          DOI: 10.1093/schbul/sbp094

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  53 in total

1.  Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study.

Authors:  Abraham Reichenberg; Mark Weiser; Michael A Rapp; Jonathan Rabinowitz; Asaf Caspi; James Schmeidler; Haim Y Knobler; Gad Lubin; Daniela Nahon; Philip D Harvey; Michael Davidson
Journal:  Schizophr Res       Date:  2006-04-19       Impact factor: 4.939

2.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort.

Authors:  Mary Cannon; Avshalom Caspi; Terrie E Moffitt; HonaLee Harrington; Alan Taylor; Robin M Murray; Richie Poulton
Journal:  Arch Gen Psychiatry       Date:  2002-05

3.  Stability and course of neuropsychological deficits in schizophrenia.

Authors:  R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  2001-01

4.  Effect of symptoms on executive function in bipolar illness.

Authors:  T Dixon; E Kravariti; C Frith; R M Murray; P K McGuire
Journal:  Psychol Med       Date:  2004-07       Impact factor: 7.723

5.  A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.

Authors:  Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore
Journal:  J Affect Disord       Date:  2006-03-06       Impact factor: 4.839

6.  Letter and category fluency in schizophrenic patients: a meta-analysis.

Authors:  Christina E Bokat; Terry E Goldberg
Journal:  Schizophr Res       Date:  2003-11-01       Impact factor: 4.939

Review 7.  A review of longitudinal studies of cognitive functions in schizophrenia patients.

Authors:  B R Rund
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

8.  Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

Authors:  Abraham Reichenberg; Philip D Harvey; Christopher R Bowie; Ramin Mojtabai; Jonathan Rabinowitz; Robert K Heaton; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

9.  The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients.

Authors:  Emre Bora; Simavi Vahip; Fisun Akdeniz; Ali Saffet Gonul; Ayse Eryavuz; Melise Ogut; Muge Alkan
Journal:  Bipolar Disord       Date:  2007-08       Impact factor: 6.744

10.  Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

Authors:  Richard S E Keefe; John A Sweeney; Hongbin Gu; Robert M Hamer; Diana O Perkins; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

View more
  57 in total

1.  General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

Authors:  Alex Fornito; Jong Yoon; Andrew Zalesky; Edward T Bullmore; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

2.  Relationship between MEG global dynamic functional network connectivity measures and symptoms in schizophrenia.

Authors:  L Sanfratello; J M Houck; V D Calhoun
Journal:  Schizophr Res       Date:  2019-05-24       Impact factor: 4.939

3.  Anticipating DSM-V: opportunities and challenges for cognition and psychosis.

Authors:  Deanna M Barch; Richard S E Keefe
Journal:  Schizophr Bull       Date:  2009-11-18       Impact factor: 9.306

4.  Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.

Authors:  Aurelia Ces; David Reiss; Ondine Walter; Jürgen Wichmann; Eric P Prinssen; Brigitte L Kieffer; Abdel-Mouttalib Ouagazzal
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

5.  Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?

Authors:  Stephen M Lawrie; Bayanne Olabi; Jeremy Hall; Andrew M McIntosh
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

6.  Shared intermediate phenotypes for schizophrenia and bipolar disorder: neuroanatomical features of subtypes distinguished by executive dysfunction.

Authors:  Alana M Shepherd; Yann Quidé; Kristin R Laurens; Nicole O'Reilly; Jesseca E Rowland; Philip B Mitchell; Vaughan J Carr; Melissa J Green
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

7.  Self-reported sleep disturbances associated with procedural learning impairment in adolescents at ultra-high risk for psychosis.

Authors:  Jessica R Lunsford-Avery; Derek J Dean; Vijay A Mittal
Journal:  Schizophr Res       Date:  2017-03-16       Impact factor: 4.939

8.  Stereological investigation of the posterior hippocampus in affective disorders.

Authors:  Berend Malchow; Steffen Strocka; Friederike Frank; Hans-Gert Bernstein; Johann Steiner; Thomas Schneider-Axmann; Alkomiet Hasan; Daniela Reich-Erkelenz; Christoph Schmitz; Bernhard Bogerts; Peter Falkai; Andrea Schmitt
Journal:  J Neural Transm (Vienna)       Date:  2014-10-12       Impact factor: 3.575

9.  The involvement of Type II Neuregulin-1 in rat visuospatial learning and memory.

Authors:  Adam R Taylor; Sara B Taylor; James I Koenig
Journal:  Neurosci Lett       Date:  2012-10-23       Impact factor: 3.046

Review 10.  Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes.

Authors:  Alkomiet Hasan; Wolfgang Strube; Ulrich Palm; Thomas Wobrock
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.